Thought Leadership
Blog & Article
- 17th December 2024
Infographic
Our Local Pharmacovigilance Services (LPVS) help you to navigate complex regional and local PV regulatory requirements and drive growth. Scale quickly without compromising quality – helping avoid common safety-related delays in product submissions, authorizations, and marketing.
Journal Article
The use of contract development manufacturing organisations (CDMOs) is now the established norm in the pharma/medtech supply chain. The CDMO model provides cost-effective, reliable and compliant solutions with speed to market for critical healthcare products. It takes advantage of core competencies/experience from the contract giver (eg, brand development, marketing, etc) and contract acceptor (eg, manufacturing excellence, quality operations, etc) to allow for targeted focus on key operational pillars to ensure overall programme success and synergies.
Journal Article
The EU legislation for substances of human origin (SoHOs) has been revised, bringing blood products, tissues and cells under one regulation.
Journal Article
Page 59 – Zielgerichtete Therapien haben die moderne Medizin grundlegend verändert. Die Entwicklung dieser Medikamente kann jedoch herausfordernd sein.
Journal Article
Combination-product growth has surged globally as both physicians and patients request fewer invasive procedures in favor of user-friendly treatment delivery options.
